All pathogenesis and death associated with Plasmodium falciparum malaria is due to parasite-infected erythrocytes. Invasion of erythrocytes by P. falciparum merozoites requires specific interactions between host receptors and parasite ligands that are localized in apical organelles called micronemes. Here, we identify cAMP as a key regulator that triggers the timely secretion of microneme proteins enabling receptor-engagement and invasion. We demonstrate that exposure of merozoites to a low K+ environment, typical of blood plasma, activates a bicarbonate-sensitive cytoplasmic adenylyl cyclase to raise cytosolic cAMP levels and activate protein kinase A, which regulates microneme secretion. We also show that cAMP regulates merozoite cytosolic Ca2+ levels via induction of an Epac pathway and demonstrate that increases in both cAMP and Ca2+ are essential to trigger microneme secretion. Our identification of the different elements in cAMP-dependent signaling pathways that regulate microneme secretion during invasion provides novel targets to inhibit blood stage parasite growth and prevent malaria.
All the clinical symptoms of Plasmodium falciparum malaria are attributed to the blood stage of the parasite life cycle. The intra-erythrocytic stage of the life cycle is initiated when liberated P. falciparum merozoites invade and multiply within host red blood cells. Following the development of mature schizonts, next generation merozoites egress from infected erythrocytes and invade uninfected erythrocytes to start a new cycle of infection. Invasion of erythrocytes by P. falciparum merozoites is a complex multi-step process that is mediated by specific molecular interactions between red cell surface receptors and parasite protein ligands [1], [2]. A number of parasite ligands that mediate receptor binding during invasion reside in apical membrane-bound organelles known as micronemes and rhoptries [1], [2]. Timely secretion of these parasite ligands to the merozoite surface is critical for successful invasion [3], [4]. Microneme and rhoptry proteins are secreted from free P. falciparum merozoites in a two-step process [5]. First, exposure of extracellular merozoites to a low [K+] environment typical of blood plasma leads to a rise in cytosolic Ca2+ via a phospholipase C (PLC) -dependent pathway, which triggers translocation of microneme proteins such as 175 kD erythrocyte binding antigen (EBA175) and apical merozoite antigen-1 (PfAMA1) to the merozoite surface [5]. Subsequently, binding of EBA175 and its homologs to their erythrocyte receptors triggers secretion of rhoptry proteins such as PfRH2b, Clag3. 1 and PfTRAMP [5], [6]. The pathways by which exposure of P. falciparum merozoites to a low K+ environment triggers a rise in cytosolic Ca2+ and microneme secretion are not understood. Here, we demonstrate that another ubiquitous second messenger, namely, 3' -5' cyclic adenosine monophosphate (cAMP), plays a central role in regulating cytosolic Ca2+ levels and microneme secretion during merozoite invasion of red blood cells. We demonstrate that exposure of merozoites to a low K+ environment as found in blood plasma activates the bicarbonate-sensitive cytoplasmic adenylyl cyclase β (PfACβ) leading to a rise in cytosolic cAMP levels and activation of protein kinase A (PKA), which regulates microneme secretion. In mammalian cells, the cAMP responsive PKA, which regulates diverse cellular processes in response to a rise in cytosolic cAMP levels, is composed of two catalytic subunits and two regulatory subunits [7]. Unlike mammalian cells, P. falciparum has a single inhibitory regulatory subunit (PfPKAr) and a single catalytic subunit (PfPKAc) [8]–[12]. As the PfPKAr subunit is not predicted to dimerize, the holoenzyme is likely to be composed of a one-to-one ratio of PfPKAr∶PfPKAc [12]. The PfPKAr subunit is predicted to have 2 cyclic nucleotide binding domains. When cAMP binds to one or both of these it provokes a conformational change that engenders the dissociation of the PfPKAr∶PfPKAc complex and activation of the released PfPKAc subunit that phosphorylates its specific substrates [8]–[12]. Like Plasmodium, Toxoplasma also encodes cAMP-dependent PKA and its inhibition leads to a block in tachyzoite growth [13]. Increase in cytosolic cAMP levels that would activate Toxoplasma PKA also mediates the tachyzoite to bradyzoite developmental switch [14]–[16]. In addition to activating PKA, we demonstrate that cAMP activates the Epac pathway [17] in P. falciparum merozoites, which triggers a rise in cytosolic Ca2+ leading to microneme release. cAMP thus plays a central role in regulating microneme secretion during red blood cell invasion by P. falciparum merozoites.
cAMP is produced in eukaryotic cells either by a transmembrane adenylyl cyclase (tmAC), which has a putative K+ channel at the N-terminus, or by a cytoplasmic soluble adenylyl cyclase (sAC). Homologs of both the tmAC (PF3D7_1404600) and sAC (PF3D7_0802600) (www. plasmodb. org) are encoded in P. falciparum genome [18], [19]. However, the gene encoding the P. berghei transmembrane AC (PbACα) has been knocked out with no deleterious effect on growth of blood stage parasites although sporozoites are impaired in hepatocyte infectivity [20]. Given that PbACα does not appear to have an essential role in blood stage growth we focused our attention on the soluble AC in P. falciparum (PfACβ). Mouse antiserum raised against a synthetic peptide derived from PfACβ detects a protein of expected size (>250 kD) in schizont and merozoite lysates by Western blotting (S1 Figure). Detection of PfACβ by immunofluorescence assay (IFA) demonstrates that it co-localizes in late stage schizonts and merozoites with the cytoplasmic protein PfNapL [21] (Fig. 1). PfACβ is thus expressed in P. falciparum merozoites and is localized in the cytoplasm. Exposure of P. falciparum merozoites to an ionic environment with low K+ as found in blood plasma triggers a rise in cytosolic Ca2+ and secretion of microneme proteins [5]. To determine if exposure of free merozoites to a low K+ environment also leads to a rise in cytosolic cAMP, we measured cAMP levels in purified merozoites suspended in a buffer that mimics the intracellular ionic environment (IC buffer – 140 mM KCl, 5 mM NaCl, 1 mM MgCl2,5. 6 mM glucose, 25 mM HEPES, pH 7. 2) and following transfer to a buffer that mimics extracellular ionic environment with low K+ levels (EC buffer – 5 mM KCl, 140 mM NaCl, 1 mM MgCl2,2 mM EGTA, 5. 6 mM glucose, 25 mM HEPES, pH 7. 2). cAMP levels were also measured before and after merozoites were transferred from IC to IC-Klow buffer (IC-Klow buffer – 5 mM NaCl, 5 mM KCl, 135 mM choline-Cl, 1 mM EGTA, 5. 6 mM glucose, 25 mM HEPES, pH 7. 2) to determine if change in environmental K+ level alone can trigger changes in cAMP levels. There is a distinct rise in cAMP when merozoites are transferred from IC to EC buffer, or from IC to IC-Klow buffer (Fig. 1B). Importantly, transfer of free merozoites to a low K+ buffer in the presence of KH7, which inhibits mammalian sAC [19], blocks the rise in cytosolic cAMP (Fig. 1C). We monitored the secretion of microneme protein PfAMA1 following the transfer of free P. falciparum merozoites from IC to EC buffer with or without prior treatment with KH7. PfAMA1 is proteolytically cleaved into 48 kD and 44 kD fragments that are released into the supernatant following translocation to the merozoite surface [22]. PfAMA1 was detected in merozoite supernatants following transfer from IC to EC buffer by Western blotting using anti-PfAMA1 sera (Fig. 1D). Transfer of extracellular merozoites from IC to EC buffer in the presence of KH7 blocks the secretion of PfAMA1 (Fig. 1D). Treatment of merozoites with KH7 in the presence of 3-isobutyl-1-methylxanthine (IBMX), which inhibits 3’, 5’-cAMP phosphodiesterase (PDE) and maintains high cAMP levels in cells [23], reverses the block in microneme secretion (Fig. 1D). Secretion of another microneme protein, EBA175, is also inhibited if merozoites are treated with KH7 prior to transfer from IC to EC buffer (S2 Figure). Production of cAMP by soluble adenylyl cyclases is regulated by HCO3− ions in diverse organisms [24]–[26]. Incubation of P. falciparum merozoite lysates with ATP and different concentrations of HCO3− ions showed that increasing amounts of cAMP are produced in presence of increasing concentrations of HCO3− ions suggesting the presence of a HCO3− sensitive adenylyl cyclase activity (Fig. 2A). Moreover, cAMP production is inhibited by KH7 (Fig. 2A). These observations confirm the presence of a HCO3−-sensitive ACβ in free P. falciparum merozoites. Cytosolic pH (pHi) is controlled in eukaryotic cells by carbonic anhydrase (CA), which catalyzes the reversible hydration of CO2 to produce H+ and HCO3− (CO2+H2O↔HCO3−+H+) [27]. Acetazolamide (ACTZ), a specific inhibitor of CA, can disrupt intracellular pH homeostasis [28], [29]. We tested whether the transfer of free merozoites from IC to EC buffer in presence of ACTZ affects pHi. P. falciparum merozoites collected in IC buffer were loaded with the membrane permeable pH-sensitive fluorescent dye BCECF-AM [30] and transferred to EC buffer in the presence or absence of ACTZ. pHi does not change when free merozoites are transferred from IC to EC buffer. In contrast, there is a rapid rise in pHi when free merozoites are transferred from IC to EC buffer in presence of ACTZ (Fig. 2B). These observations indicate that PfCA activity is necessary for maintenance of pHi when merozoites are transferred to a low K+ environment. The observation that pHi rises when merozoites are transferred to EC in presence of ACTZ is consistent with a model in which PfCA maintains pHi by producing H+ and HCO3−. To test whether the generation of HCO3− in free merozoites following transfer from IC to EC buffer leads to activation of PfACβ, we measured levels of cAMP in merozoites with or without treatment with ACTZ. Treatment of merozoites with ACTZ prior to transfer from IC to EC buffer inhibits rise in cAMP (Fig. 2C) as well as secretion of PfAMA1 (Fig. 2D). Treatment of P. falciparum merozoites with ACTZ in presence of IBMX reverses the block in microneme secretion (Fig. 2D). These results suggest that when free merozoites are exposed to an extracellular-like low K+ environment, the production of HCO3− by PfCA to maintain pHi leads to activation of PfACβ and generation of cAMP, which triggers microneme secretion. Exposure of merozoites in IC buffer to increasing concentrations of HCO3− also leads to a dose-dependent increase in microneme secretion (S3 Figure) confirming that HCO3− plays a key role in regulating microneme secretion. PKA commonly plays a role as a cAMP-responsive effector in signaling pathways [7]. To investigate the potential role of PfPKA in microneme discharge, we measured phosphorylation of kemptide, a specific substrate of PKA, by lysates of P. falciparum merozoites in IC and EC buffers with and without addition of KH7. There is a distinct increase in kemptide phosphorylation with lysates made from merozoites in EC buffer compared to IC buffer (Fig. 3A). Pre-treatment with KH7 inhibits this increase in kemptide phosphorylation by merozoite lysates in EC buffer suggesting that a cAMP-responsive kinase is activated when merozoites are transferred to EC buffer (Fig. 3A). We used a molecular genetic approach to explore the regulatory role of PfPKA in microneme secretion. The P. falciparum transgenic line PHL dhfr-PfPKAr over-expresses the regulatory subunit (PfPKAr) (11, S4 Figure). Overexpression of PfPKAr results in reduced PKA activity and a parasite growth defect, which is restored by addition of the non-hydrolyzable cAMP analog dibutryl-cAMP (DiB) [11]. In contrast to wild type P. falciparum merozoites (Fig. 3A), lysates of P. falciparum PHL dhfr-PfPKAr merozoites in EC buffer do not phosphorylate kemptide at higher levels compared to lysates made in IC buffer (Fig. 3B). Treatment of P. falciparum PHL dhfr-PfPKAr merozoite lysates with DiB increases kemptide phosphorylation (Fig. 3B). These observations indicate that kemptide phosphorylation is primarily due to PfPKA and PfPKA activity increases when merozoites are transferred from IC to EC buffer. Next, we followed secretion of PfAMA1 upon transfer of P. falciparum PHL dhfr-PfPKAr merozoites from IC to EC buffer with and without DiB treatment (Fig. 3C). PfAMA1 is not secreted when P. falciparum PHL dhfr-PfPKAr merozoites are transferred from IC to EC buffer (Fig. 3C). However, PfAMA-1 secretion is restored when P. falciparum PHL dhfr-PfPKAr merozoites are treated with DiB in EC buffer presumably due to the activation of PfPKA (Fig. 3C). These observations suggest that PfPKA plays a role in regulation of microneme secretion. Impairment of microneme secretion due to PfPKAr overexpression may be one of the reasons for poor growth of P. falciparum PHL dhfr-PfPKAr parasites. Changes in the levels of cytosolic Ca2+ and cAMP control a variety of functions in diverse cell types [31]. We examined the crosstalk between these two ubiquitous second messengers in extracellular P. falciparum merozoites. We found that treatment of merozoites with the Ca2+ chelator, BAPTA-AM, or PLC inhibitor, U73122, does not affect the increase in cAMP levels when merozoites are transferred from IC to EC buffer (Fig. 4A). In contrast, treatment of merozoites with the ACβ inhibitor KH7 inhibits the increase in cytosolic Ca2+ levels when merozoites are transferred from IC to EC buffer (Fig. 4B) indicating that cAMP plays a key role in regulating cytosolic Ca2+ levels in P. falciparum merozoites. Next, we found that Ca2+ levels increase in transgenic P. falciparum PHL dhfr-PKAr merozoites following their transfer from IC to EC buffer (Fig. 4B). Moreover, treatment of transgenic merozoites with DiB in IC buffer, which activates PfPKA, does not lead to further increase in cytosolic Ca2+ levels (Fig. 4C). These observations indicate that PfPKA does not play a role in generation of free cytosolic Ca2+ in P. falciparum merozoites following transfer from IC to EC buffer. Alternative cAMP-responsive effectors, Epac 1 and Epac 2, have been shown to activate phospholipase C (PLC) in presence of cAMP leading to rise in cytosolic Ca2+ in mammalian cells [17], [32], [33]. P. falciparum codes for a single putative parasite PfEpac (PF3D7_1417400). Treatment of merozoites in IC buffer with the Epac agonist, 8-pCPT-2’-O-Me-cAMP [34], leads to a rise in cytosolic Ca2+ levels (Fig. 4D). This increase in Ca2+ is blocked if merozoites are treated with ESI-09, which inhibits both mammalian Epac 1 and Epac 2 [35] (Fig. 4D). ESI-05, which only inhibits mammalian Epac 2 [36], does not block increase in cytosolic Ca2+ following treatment with the Epac agonist (Fig. 4D). In mammalian cells, Epac activated by cAMP catalyzes the transfer of GTP to Rap1 [17]. Rap1-GTP activates PLC and triggers a rise in cytosolic Ca2+ through the PLC pathway [17]. Stimulation of merozoites with the Epac agonist in presence of GGTI298 [37], [38], which disrupts Rap1 activity, or the PLC inhibitor, U73122 [5], [39], inhibits rise in cytosolic Ca2+ (Fig. 4E). Moreover, treatment of merozoites with either ESI-09 or GGTI298 prior to transfer from IC to EC buffer also blocks rise in cytosolic Ca2+ (Fig. 4F) and inhibits PfAMA1 secretion (Fig. 5A, 5B). In contrast, ESI-05, which does not inhibit increase in cytosolic Ca2+ levels (Fig. 4F), does not block secretion of PfAMA1 (Fig. 5A). Treatment of merozoites with GGT1298 together with the Ca2+ ionophore A23187 restores microneme secretion (Fig. 5B). Thus, a cAMP-responsive Epac-Rap1 pathway is likely to be involved in regulating Ca2+ levels in P. falciparum merozoites. To confirm the role of cAMP-responsive effectors PfPKA and PfEpac in microneme secretion, we treated merozoites in IC buffer with the Epac agonist, the Ca2+ ionophore A23187 and DiB, either individually or in combination. Treatment of merozoites in IC buffer with Epac agonist, A23187 or DiB individually does not trigger PfAMA1 secretion (Fig. 5C). However, treatment of merozoites in IC buffer with A23187 and DiB, or Epac-agonist and DiB triggers PfAMA1 secretion (Fig. 5C). The PLC inhibitor U73122 blocks PfAMA1 secretion induced by treatment of merozoites in IC buffer with Epac-agonist and DiB (Fig. 5D). However, the inactive analog, U73343 has no inhibitory effect. These observations suggest that Epac-agonist triggers rise in Ca2+ through the PLC pathway. Moreover, both Ca2+ and cAMP surges are required to trigger the secretion of microneme proteins in free merozoites. Erythrocyte invasion assays were performed with purified extracellular merozoites in the presence of inhibitors of cAMP- and Ca2+-mediated signaling pathways. Merozoites were treated with ACβ inhibitor KH7, the CA inhibitor ACTZ, or Epac inhibitors ESI-09 and ESI-05, and allowed to invade human erythrocytes. Successful invasion events were scored by flow cytometry using DNA intercalating dye ethidium bromide to identify infected erythrocytes. KH7, ACTZ and ESI-09 inhibit invasion (Fig. 5E) adding to the evidence that both cAMP and Ca2+-dependent signaling pathways play critical roles in the process of red cell invasion by P. falciparum merozoites.
We have previously demonstrated that exposure of merozoites to a low K+ environment, as found in blood plasma, triggers a rise in cytosolic Ca2+ through a PLC mediated pathway leading to microneme secretion [5]. Although it is clear that a rise in cytosolic Ca2+ plays a key role in regulating microneme release, the signal transduction mechanisms by which exposure of extra-erythrocytic merozoites to a low K+ environment leads to a rise in cytosolic Ca2+ were not known. Here, we demonstrate the role of cAMP in regulating levels of cytosolic Ca2+ and microneme secretion in response to exposure of merozoites to a low K+ environment. The transmembrane channel linked expressed in Paramecium, which contains a putative K+ channel-like transmembrane domain fused to the adenylyl cyclase catalytic domain, produces cAMP when the organism is exposed to a low K+ environment [18]. A homolog of tmAC, referred to as ACα is expressed in blood stage Plasmodium parasites. However, deletion of the gene encoding P. berghei ACα does not have any deleterious effect on growth of blood stage parasites [20]. In contrast, deletion of the gene encoding P. berghei ACα impairs hepatocyte invasion by P. berghei sporozoites [20]. These observations suggest that the soluble adenylyl cyclase, ACβ may play a more significant role in regulation of cAMP levels in Plasmodium merozoites. Here, we have used a series of pharmacological inhibitors to explore the role of PfACβ as well as other players involved in signaling pathways that control microneme secretion. Based on the observations made here, we propose the following model for the regulation of microneme secretion in response to environmental signals (Fig. 6). We propose that when merozoites are exposed to a low K+ environment, PfCA produces HCO3− and H+ ions to maintain pHi homeostasis (Fig. 6). Given the lack of information about the nature of ion channels present on the surface of P. falciparum merozoites, it is difficult to develop a molecular model to explain the activation of PfCA for maintenance of pHi leading to production of HCO3− when merozoites are exposed to a low K+ environment. Production of HCO3− by PfCA activates PfACβ leading to a surge in cAMP levels in free merozoites (Fig. 6). Treatment of merozoites with CA inhibitor, ACTZ, or PfACβ inhibitor, KH7, blocks production of cAMP and inhibits microneme secretion. cAMP thus serves as a key second messenger that regulates microneme secretion in free merozoites during red cell invasion (Fig. 6). Next, we demonstrated that production of cAMP in merozoites leads to activation of the cAMP-responsive kinase, PfPKA. We confirmed using a genetic approach that PfPKA plays a role in microneme secretion. Over-expression of the regulatory subunit, PfPKAr, inhibits PfPKA activity and blocks microneme secretion implicating PfPKA in regulation of microneme secretion. PfPKA has been shown to phosphorylate the cytoplasmic domain of PfAMA1 during invasion [40], although the precise functional role in the invasion process is not yet known. A global study of changes in protein phosphorylation in merozoites following their transfer to a low K+ environment is needed to identify the signaling pathways involved in microneme secretion. Determination of changes in protein phosphorylation in the presence and absence of PfPKA inhibition will identify substrates of PfPKA that may be involved in microneme secretion and invasion. Given the essential roles that both Ca2+ and cAMP play in regulating microneme secretion in free merozoites, we examined the crosstalk between these key second messengers. Inhibiting rise in cytosolic Ca2+ by treatment of merozoites with BAPTA-AM or PLC inhibitor U73122 does not affect rise in cAMP when merozoites are exposed to a low K+ environment. In contrast, blocking a rise in cAMP with KH7 does inhibit increase in cytosolic Ca2+ levels. Thus, a rise in cAMP levels precedes and is necessary for an increase in cytosolic Ca2+ when merozoites are exposed to a low K+ environment. We explored the mechanism by which cAMP regulates cytosolic Ca2+ levels in merozoites and found that PfEpac, rather than PfPKA, is responsible. We present pharmacological evidence to indicate that merozoites possess functional homologs of Epac and Rap1 that activate PLC to trigger a rise in cytosolic Ca2+ in response to increase in cAMP levels. A potential PfEpac is encoded by PF3D7_1417400 (www. plasmodb. org). A search for Rap1 homologs identifies a number of P. falciparum genes predicted to encode small GTPases. It remains to be seen which one these is the functional homolog of Rap1 that activates PLC in response to rise in cAMP in P. falciparum merozoites. Previous studies with mature schizonts demonstrated that activation of a cGMP-dependent protein kinase, PfPKG, triggers release of proteins from micronemes and exonemes in merozoites leading to egress [41]. Secretion of exoneme proteins such as the protease PfSUB1 plays a critical role in merozoite egress from infected erythrocytes [42], [43]. The external, or internal signals that trigger a rise in cGMP and activate PfPKG leading to egress are not known. A sharp rise in cytosolic Ca2+ in intra-erythrocytic merozoites is also observed just prior to release of microneme and exoneme proteins and parasite egress [5], [43], [44]. The pathways for crosstalk between cGMP and Ca2+ in P. falciparum merozoites during egress have not been defined and whether cGMP-dependent PfPKG plays a role in microneme secretion in free merozoites after egress is not known. It will be important to understand the crosstalk between cGMP, cAMP and Ca2+ in merozoites leading to apical organelle exocytosis both before and after egress. One possible mechanism for such crosstalk may be through phosphorylation of the PfPKAr subunit by PfPKG that would relieve inhibition of the catalytic PfPKAc subunit. PfPKAr displays characteristics of both mammalian RI and RII subunits [12]. Mammalian RI and RII subunits have distinct inhibitor sites. PfPKAr has a serine in the P-site typical of RII subunits and is phosphorylated by PfPKA in vitro [12]. However, PfPKAr also has a serine in the P+2 site typical of RI subunits. In mammalian cells this site is phosphorylated by PKG [45]. Like the P-site, the P+2 site in PfPKAr is also phosphorylated in vivo in P. falciparum schizonts [46]. Moreover, PfPKG can phosphorylate PfPKAr in vitro (Baker D. and Langsley G. , unpublished data). Thus, PfPKG phosphorylation of PfPKAr could provide a mechanism for crosstalk between cGMP- and cAMP-mediated signaling. A recent study describes a different mechanism for elevation of cytosolic Ca2+ in merozoites leading to microneme release [47]. This study suggests that interaction of the rhoptry neck protein PfRH1 with its erythrocyte receptor can trigger a surge in cytosolic Ca2+ levels in merozoites leading to release of microneme proteins such as EBA175 [47]. It remains to be seen if cAMP levels also rise and play a role in regulating Ca2+ levels following receptor-engagement by PfRH1. Moreover, the observation that PfRH1 knock-out parasites invade erythrocytes efficiently and display normal blood stage growth [48] suggests that P. falciparum merozoites must have alternative signaling mechanisms to trigger microneme release. Whether other members of the PfRH family such as PfRH2a/b can also mediate rise in cytosolic Ca2+ and microneme release remains to be determined. Alternatively, as described here, exposure to low K+ as found in blood plasma may provide such an alternative mechanism to trigger rise in cytosolic Ca2+ and microneme release. Our study demonstrates that cAMP plays a central role in regulating microneme secretion during invasion (Fig. 6). Our data provides evidence to suggest that cAMP not only regulates microneme secretion by activating PfPKA, but it also regulates cytosolic Ca2+ levels by activation of PfEpac. Our definition of the signal transduction pathways leading to rise in cAMP and Ca2+ levels in response to external signals and the identification of cAMP and Ca2+ responsive effectors provides multiple points for therapeutic intervention. For example, inhibition of PfCA, PfACβ and PfEpac blocks microneme secretion and red blood cell invasion by P. falciparum merozoites. Small molecule inhibitors that specifically target these key-signaling molecules may provide valuable leads for the development of novel anti-malarial drugs that block blood stage growth of malaria parasites.
P. falciparum 3D7 was cultured in complete RPMI (RPMI 1640 (Invitrogen, USA), 27. 2 mg/L hypoxanthine (Sigma, USA), 0. 5 gms/L Albumax I (Gibco, USA) and 2 gm/L sodium bicarbonate (Sigma, USA) using O+ human erythrocytes under mixed gas (5% O2,5% CO2 and 90% N2) as described previously [49]. P. falciparum PHL dhfr-PfPKAr was cultured in complete RPMI according to the protocol described previously [11]. A peptide (1916–1930 aa) derived from PfACβ (PlasmoDB ID PF3D7_0802600) was synthesized, conjugated to keyhole limpet hemocyanin (KLH) and used to immunize mice to obtain anti-PfACβ specific antibodies. The coding sequence of PfPKAr was amplified by PCR from P. falciparum cDNA with primers containing BamHI and XhoI restriction sites. The fragment was inserted into pCR2. 1-TOPO and verified by sequencing. After digestion by XhoI and BamHI the insert was cloned into pGEX6P-1 (GE Healthcare) and transformed into E. coli BL21 that were grown in 50 mL of LB medium containing ampicillin (100 µg/mL, Euromedex). Recombinant protein expression was induced at 30°C for 4 h by addition of 0. 2 mM IPTG (Euromedex). Cells were collected by centrifugation and lysed by sonication in lysis buffer (1× PBS-1 mM salt, 1% Triton, EDTA, protease inhibitors). The lysate was centrifuged (15000 rpm, 4°C, 60 min) and the soluble fraction incubated with glutathione sepharose beads (GE Healthcare) with stirring at 4°C for 90 min. Beads were washed with buffer (1× PBS, 1% Triton, 1 mM EDTA), the GST-tagged recombinant protein was eluted using increasing concentrations of glutathione. Purified recombinant antigen was used to immunize two rats to obtain anti-PfPKAr specific antibodies. PfPKAc was cloned in the same way as PfPKAr. To increase stability of the recombinant catalytic subunit, we co-expressed PfPKAc-His with PfPKAr-GST in E. coli BL21. Transformed bacteria were grown in 50 mL of LB medium containing ampicillin (100 µg/mL, Euromedex). Recombinant protein expression was induced at 37°C for 4 h by addition of 0. 5 mM IPTG (Euromedex). The bacterial pellet was washed once with 4 volumes of PBS and lysed using 4 volumes of Tris 20 mM at 4°C. After sonication, the lysate was centrifuged (6000 g, 4°C, 15 min) and the pellet resuspended in 3 volumes of inclusion body wash solution (2 M Urea, 500 mM NaCl, 2% NP40,20 mM Tris-HCl, pH 8. 0). The inclusion bodies were solubilised (5 mM Imidazole, 1 mM β-mercaptoethanol, 6 M Guanidine-HCl 6M, 20 mM Tris-HCl pH 8. 0) and recombinant protein purified by metal affinity chromatography. His-tagged PfPKAc was eluted (8 M Urea to 0 M Urea, 20 mM imidazole to 500 mM imidazole, 500 mM NaCl, 1 mM β-mercaptoethanol, 20 mM Tris-Hcl pH 8. 0) and used to immunize two rabbits to obtain anti-PfPKAc specific antibodies. P. falciparum blood stage cultures were synchronized with 5% sorbitol for at least two successive cycles. Synchronized P. falciparum cultures were used to isolate merozoites as described previously [5], [43]. Briefly, when majority of infected erythrocytes reached mature schizont stage with prominent segmentation of merozoites, the culture was resuspended in IC buffer (IC buffer – 140 mM KCl, 5 mM NaCl, 1 mM MgCl2,5. 6 mM glucose, 25 mM HEPES, pH 7. 2) and schizonts were allowed to rupture to release merozoites over one hour at 37°C. Unruptured scizonts and uninfected erythrocytes were separated by centrifugation at 500 g for 5 min. The supernatant containing free merozoites was centrifuged at 3300 g for 5 min to collect merozoites. The merozoites were resuspended in IC buffer. The purity of merozoite preparations was confirmed by Giemsa staining (S5 Figure). Viability of merozoite preparations was estimated by labeling merozoites with dihydroethidine. Fluorescent merozoites were scored by flow cytometry and viability of merozoite preparations was estimated to be ∼65%. P. falciparum merozoites were isolated in IC buffer and treated for 15 mins with the following at concentrations shown: 100 µM IBMX (3-isobutyl-1-methylxanthine, Calbiochem, USA), 50 µM KH7 (Calbiochem, USA), 100 µM ACTZ (acetazolamide, Sigma, USA), 20 µM DiB-cAMP (adenosine 3,5 cyclic monophosphate, N6, O2- dibutyryl sodium salt, Calbiochem, USA), 10 µM Ca2+ ionophore A23187 (Calbiochem, USA), 50 µM BAPTA-AM (Calbiochem, USA), 10 µM U73122 (Calbiochem, USA), 10 µM U73343 (Calbiochem, USA), 200 µM Epac agonist (8-pCPT-2’-O-Me-cAMP, Sigma, USA), 25 µM Epac antagonist ESI-05 (Biolog, Germany), 25 µM Epac antagonist ESI-09 (Biolog, Germany) and 50 µM geranyl geranyl transferase inhibitor, GGTI 298, which disrupts Rap1 function. Merozoites were then transferred to EC buffer (5 mM KCl, 140 mM NaCl, 1 mM MgCl2,2 mM EGTA, 5. 6 mM glucose, 25 mM HEPES, pH 7. 2) followed by either measurement of cytosolic cAMP and Ca2+ levels in merozoites or microneme secretion. P. falciparum merozoites were isolated in IC buffer (140 mM KCl, 5 mM NaCl, 1 mM MgCl2,5. 6 mM glucose, 25 mM HEPES, pH 7. 2), incubated for 15 min at 37°C with or without various pharmacological inhibitors or agonists as described above and transferred to EC buffer (5 mM KCl, 140 mM NaCl, 1 mM MgCl2,2 mM EGTA, 5. 6 mM glucose, 25 mM HEPES, pH 7. 2) or IC-Klow buffer (5 mM NaCl, 5 mM KCl, 135 mM choline-Cl, 1 mM EGTA, 5. 6 mM glucose, 25 mM HEPES, pH 7. 2) with or without pharmacological inhibitors or agonists for 15 min at 37°C. Merozoites were separated by centrifugation as described above. Merozoite supernatants and merozoite pellets were separated by SDS-PAGE on a 12% gel under reducing conditions. Microneme proteins, PfAMA1 and EBA175, were detected in merozoite supernatants by Western blotting using anti-PfAMA1 and anti-EBA175 rabbit sera, respectively. Rabbit sera against cytoplasmic protein PfNapL were used to detect PfNapL in supernatants and merozoite pellets to estimate cell lysis and confirm that similar amounts of merozoites were used for each condition, respectively. Horseradish peroxidase (HRP) -conjugated anti-rabbit IgG goat antibodies (Sigma, USA) were used as secondary antibodies and detected by enhanced chemi-luminescence using ECL-Prime Western Blotting Detection reagent (GE Healthcare). P. falciparum merozoites were lysed with 0. 1 N HCl and clarified by centrifugation at 6000 g. Supernatants were used for measuring the cytosolic levels of cAMP using cAMP direct immunoassay kit (Calbiochem, USA) as per manufacturer’s protocol. The kit uses a polyclonal antibody to bind cAMP present in the sample in a competitive manner. A standard curve was generated using known amounts of cAMP standards provided in the kit. Quantitative measurement of cAMP was obtained from the equation derived from the standard curve. The total protein content in each merozoite lysate sample was determined using Pierce BCA Protein Assay Kit (Pierce, USA) based on bicinchoninic acid (BCA). The amount of cAMP per µg of protein in each merozoite lysate sample was determined and used to calculate fold increase in cAMP per µg of merozoite protein material in each sample compared to control (merozoites in IC buffer). P falciparum merozoites were isolated in RPMI 1640 as described, washed twice with phosphate buffered saline (PBS) and resuspended in 50 mM Tris pH 7. 5,150 mM NaCl. Merozoites were lysed by repeated freeze-thaw cycles and the lysate was clarified by centrifugation at 6000 g for 1 min at 4°C. The supernatant was incubated with different concentrations of NaHCO3 (0 mM, 10 mM, 20 mM and 40 mM) in the presence of 10 mM MgCl2,10 mM CaCl2,5 mM ATP and 500 µM IBMX for 30 min at 30°C. The soluble adenylyl cyclase inhibitor KH7 (50 µM) was used as negative control. The reactions were stopped by the addition of 0. 1 N HCl and the level of cAMP produced was measured using the cAMP direct immunoassay kit as described above. P. falciparum merozoites were isolated as described above and incubated with or without KH7 (50 µM) in IC buffer for 15 min prior to transfer to EC buffer. Merozoite pellets were collected by centrifugation at 3000 g and used immediately to measure cAMP-dependent protein kinase A (PKA) activity. Merozoites were resuspended in ice-cold TNET buffer (50 mM Tris 7. 4,150 mM NaCl, 1 mM EDTA, and 1% Triton, protease inhibitor cocktail (Pierce, USA), 50 mM Na3VO4,50 mM NaF) and lysed by repeated freeze-thaw cycles (4 cycles). The lysates were cleared by centrifugation at 6000 g for 15 min at 4°C. Total amount of protein in the supernatant was determined by (bicinchoninic acid assay (BCA) (Pierce, USA) using known amounts of bovine serum albumin (BSA) as standard. PKA activity was measured by quantitating incorporation of 32P in kemptide, a known peptide substrate of PKA (L-R-R-A-S-L-G, Kemptide PKA peptide substrate, Promega, USA) as described previously [9]. Intracellular pH (pHi) of P. falciparum merozoites was measured using the pH-sensitive fluorescent dye BCECF (2′, 7′-bis- (2-carboxyethyl) -5- (and-6) -carboxyfluorescein) [30], [50]. P. falciparum merozoites were isolated in RPMI 1640 and loaded with BCECF-AM (acetoxymethylester of BCECF, Invitrogen, USA) for 20 min at 37°C in IC buffer. The merozoites were washed to remove excess dye and incubated with or without ACTZ in IC buffer at 37°C for 10 min. Merozoites were collected by centrifugation and resuspended in IC or EC buffer in the presence or absence of ACTZ and transferred to a 96 well microtiter plate (200 µL/well). Samples were excited monochromatically with λ1 = 440 nm and λ2 = 492 nm in succession for 0–10 minutes and emission was recorded at 535 nm on a fluorimeter (Perkin-Elmer Victor, USA). A quantitative measure of the pHi is provided by the ratio of the fluorescence measured at 535 nm following excitation at 492 nm and 440 nm. For each experiment, a pH calibration curve was prepared by resuspending merozoites in buffer containing 130 mm KCl, 25 mM HEPES, 20 mM glucose and 1 mM MgCl2 with a pH range of 6. 6 to 8. 0 followed by the addition of 10 µm nigericin (Sigma). Nigericin equilibrates the intracellular and extracellular pH. The equation derived from the linear regression curve obtained by plotting the fluorescence ratio at different pH values (S6 Figure) was used to calculate pHi of merozoites in different conditions. P. falciparum merozoites were isolated as described above, loaded with 10 µM Fluo-4-AM for 20 min at 37°C, washed, resuspended in IC buffer and used for experiments within 5 min, as described earlier [5], [51]. Fluo-4-AM loaded P. falciparum merozoites were treated with cAMP or Ca2+ modulating agents and transferred from IC to EC buffer. Fluorescence signal from Fluo-4 in merozoites under different conditions was measured by flow cytometry using FACSCalibur (Becton Dickinson, USA) and analyzed using CellQuest software. Briefly, Fluo-4-AM loaded merozoites were excited at 488 nm and fluorescence signal was detected with a 430 nm/30 nm band pass filter for periods of 2–3 mins. Merozoites were gated on the basis of their forward scatter and side scatter. The mean fluorescence intensity (MFI), which reflects cytosolic Ca2+ levels in merozoites, was plotted against time using FlowJo software. P. falciparum merozoites isolated as described above were either mock-treated or treated with 50 µm KH7 (Calbiochem, USA), 100 µm ACTZ (Sigma, USA), 25 µM ESI-05 (Biolog, Germany) or 25 µM ESI-09 (Biolog, Germany) for 15 min at 37°C, washed with IC buffer, resuspended in EC buffer and incubated with erythrocytes in EC buffer at 37°C under mixed gas environment for 2 h to allow invasion. EC buffer was then replaced with complete RPMI. After 18–20 h of incubation in complete RPMI under mixed gas environment to allow development of ring stages, the percentage of infected erythrocytes was scored by flow cytometry to determine invasion rates, as described earlier [52]. P. falciparum schizonts and merozoites were smeared on glass slides, dried and fixed with pre-chilled methanol. Smears were blocked with 3% BSA in 1× PBS for 2 h at room temperature (RT) and probed with anti-PfACβ mouse sera diluted 1∶100, followed by Alexa-Fluor 488 conjugated goat anti-mouse IgG antibody diluted 1∶200. For co-immuno-staining, smears were also probed with rabbit sera (1∶100 dilution) against the cytoplasmic protein PfNAPL [20]. After washing, smears were incubated with Alexa-Fluor 488-conjugated goat anti-mouse IgG (1∶200, Molecular Probes, USA) and Alexa-Fluor 594-conjugated goat anti-rabbit IgG (1∶200 dilution, Molecular Probes, USA), for 1 hr at RT. The slides were washed, mounted with 4′, 6-diamidino-2-phenylindole dihydrochloride (DAPI, Molecular Probes, USA) and antifade mounting media (Molecular Probes, USA) and analyzed using a Nikon A1-R confocal microscope.
The blood stage of malaria parasites is responsible for all the morbidity and mortality associated with malaria. During the blood stage, malaria parasites invade and multiply within host erythrocytes. The process of erythrocyte invasion requires specific interactions between host receptors and parasite ligands. Many of the key parasite proteins that bind host receptors are localized in apical organelles called micronemes. Here, we demonstrate that cAMP serves as a key regulator that controls the timely secretion of microneme proteins during invasion. We show that exposure of merozoites to a low K+ environment, as found in blood plasma, leads to a rise in cytosolic cAMP levels due to activation of the cytoplasmic, bicarbonate-sensitive adenylyl cyclase β (PfACβ). A rise in cAMP activates protein kinase A (PKA), which regulates microneme secretion. In addition, cAMP triggers a rise in cytosolic Ca2+ levels through the Epac pathway. Increases in both cAMP and Ca2+ levels are essential for triggering microneme secretion. Identification of the different elements in the cAMP-dependent signaling pathways that regulate microneme secretion during invasion provides novel targets to block erythrocyte invasion, inhibit blood stage parasite growth and prevent malaria.
biochemistry
cell biology
biology and life sciences
microbiology
molecular cell biology
The Central Role of cAMP in Regulating Plasmodium falciparum Merozoite Invasion of Human Erythrocytes